Enveda

Enveda is a biotechnology company that is learning from life’s chemistry to create better medicines faster. Enveda uses AI-powered tools to identify and characterize a wide range of molecules produced by living organisms.

Health and bioEducation

Enveda raised $311M in a Series B+ round announced September 23, 2026, according to fiercebiotech.com. Investors in that round: Catalio.

Raise history

1. September 29, 2026
   First seen by Recent Funding
   via startups.gallery
2. September 23, 2026
   Series B+ · $311M
   CCatalio (lead)
   Source: fiercebiotech.com (startups.gallery listing)

Investors

• CCatalio
• IICONIQ
• LLightspeed
• LLux Capital
• MMicrosoft
• PPremji Invest
• TTrue Ventures

Related other companies

• QQuartermaster$140M · Sep 28, 2026
• SSnorkel AI$350M · Sep 23, 2026
• HHeidi Health$100M · Sep 22, 2026
• FFirecrawl$75M · Sep 22, 2026
• CCorridor$25M · Sep 21, 2026
• JJack & Jill$40M · Sep 19, 2026
• MMithr Inc.$20M · Sep 19, 2026
• FFootprint$25M · Sep 16, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/enveda.